Melatonin in circadian sleep disorders in the blind

62Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Assessment of sleep patterns in blind people demonstrates a high prevalence of sleep disorders. Our studies have shown that subjects with no conscious light perception (NPL) have a higher occurrence and more severe sleep disorders than those with some degree of light perception (LP). A detailed study of 49 blind individuals showed that those with NPL are likely to have free-running (FR) circadian rhythms (aMT6s, cortisol) including sleep. Non–24-hour (or FR) sleep-wake disorder, characterised by periods of good and bad sleep is a condition that may benefit from melatonin treatment. Melatonin has been administered to NPL subjects with FR circadian rhythms and compared with placebo (or the no-treatment baseline) sleep parameters improved. The results suggest that prior knowledge of the subject’s type of circadian rhythm, and timing of treatment in relation to the individual’s circadian phase, may improve the efficacy of melatonin. © 1999 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Skene, D. J., Lockley, S. W., & Arendt, J. (1999). Melatonin in circadian sleep disorders in the blind. NeuroSignals, 8(1–2), 90–95. https://doi.org/10.1159/000014575

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free